Patent 7976871 was granted and assigned to Torrent Pharmaceuticals on July, 2011 by the United States Patent and Trademark Office.
A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.